Clinical Trial Update: Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of cediranib in patients with solid tumors and hepatic impairment has completed, evaluating how liver impairment affects drug expo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Cancer, Hepatic Impairment | Phase 1 | Status: COMPLETED